Liquid Biopsy: Current advancements in clinical practice for bladder cancer
Felice Crocetto(University of Naples Federico II), Daniela Terracciano(Federico II University Hospital), Gian Maria Busetto(University of Foggia), Vincenzo Caputo(University of Naples Federico II), Marco Finati(University of Foggia), Andrea Fuschi(Sapienza University of Rome), Raffaele Balsamo(Ospedale Monaldi), Antonio Luigi Pastore(Università Campus Bio-Medico), Roberto Bianchi(AOL (United States)), Roberto Falabella(Azienda Ospedaliera Ospedale San Carlo Borromeo), Ugo Amicuzi(University of Naples Federico II), Simone Tammaro(University of Naples Federico II), Francesco Del Giudice(Sapienza University of Rome), Matteo Ferro(Istituti di Ricovero e Cura a Carattere Scientifico), Marco Magliocchetti(University of Naples Federico II), Michele Musone(University of Naples Federico II), Dario Di Lieto(University of Naples Federico II), Giuseppe Lucarelli(University of Bari Aldo Moro)
Cited by 29
Related Papers
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190